Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) [Phase 1]
A Phase 1 clinical trial evaluating the safety and efficacy of NRT6008 in patients with unresectable locally advanced pancreatic cancer, spo…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Clinico-demographic Profile of the Patient With Pancreaticobiliary Malignancy Undergoing ERCP in a Tertiary Care Center of Nepal
A completed clinical trial update from Kathmandu University School of Medical Sciences profiling patients with pancreaticobiliary malignanci…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) [NA]
PLATON, a platform for analyzing targetable tumor mutations, completed its pilot study evaluating its utility across hepatocellular carcinom…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Improvement of Care of Patients Undergoing Pancreaticoduodenectomy [NA]
This document provides an update on a clinical trial aimed at improving perioperative care for patients undergoing pancreaticoduodenectomy.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomy [Phase 3]
Phase 3 trial comparing Cattell-Warren versus Blumgart techniques of pancreatico-jejunostomy after pancreatoduodenectomy for pancreatic canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Effects of Surgical Timing on Perioperative Clinical Outcomes in Pancreaticoduodenectomy
Completed clinical trial evaluating how the timing of pancreaticoduodenectomy affects perioperative outcomes and complications.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma [Phase 2]
Phase 2 clinical trial comparing gemcitabine alone versus gemcitabine plus vandetanib in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer. [Phase 1, Phase 2]
This clinical trial update notes the completion of a Phase 1/2 study evaluating nivolumab and ipilimumab in combination with chemoradiation …
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
A completed multicancer registry study (PREFER) assessing the prevalence of actionable biomarkers and driver mutations across advanced cance…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update for XB2001 in combination with ONIVYDE and 5-FU/leucovorin in advanced pancreatic cancer; the Phase 1/2 study is liste…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors [NA]
Completed update for the BurnAlong Pilot Study evaluating a program for adolescent and young adult cancer survivors. The study spans multipl…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Adapted Guided Stereotactic Body Radiotherapy Combined with Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND) [Phase 1, Phase 2]
A Phase 1/2 trial from Shandong Cancer Hospital and Institute is evaluating adapted guided stereotactic body radiotherapy with chemotherapy …
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours [Phase 1]
Phase 1 first-in-human study to evaluate safety, tolerability and antineoplastic activity of OATD-02 in patients with selected advanced/meta…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c) [Phase 2]
A Phase 2 clinical trial from Fudan University evaluating metformin and insulin in patients with pancreatic cancer–related diabetes (Type 3c…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab with the CXCR4 antagonist BL-8040 in metastatic pancreatic cancer has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma [Phase 2]
A Phase 2 trial evaluating carbon ion radiotherapy for resectable or borderline resectable pancreatic cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. [NA]
This clinical trial update describes an education intervention aimed at helping patients manage rash associated with epidermal growth factor…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer [Phase 3]
A pivotal Phase 3 trial is examining the safety and effectiveness of NanoKnife Irreversible Electroporation for Stage III pancreatic cancer.…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 [Phase 1]
This Phase 1 study of CMG901 in patients with advanced solid tumors, including gastric cancer and pancreatic cancer, assesses safety, tolera…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update of LYT-200 as a single agent and in combination with chemotherapy or tislelizumab in locally advanced or met…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer [Phase 2]
Phase II study evaluating MR-guided radiotherapy dose escalation for unresectable non-metastatic pancreatic cancer; results have been posted…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer [Phase 1]
A Phase 1 trial of Biomea Fusion's covalent menin inhibitor BMF-219 in KRAS-driven non-small cell lung cancer, pancreatic cancer, and colore…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Modified FOLFIRINOX (mFFX) or Gemcitabine Plus Nab-paclitaxel (GnP) Therapy as First-line Treatment in Patients With Metastatic Pancreatic Cancer [Phase 1]
Phase 1 open-label, uncontrolled study evaluating ONO-4578 and ONO-4538 in combination with standard first-line therapies (modified FOLFIRIN…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer
This clinical trial registry entry notes that the study evaluating the optimal duration of neoadjuvant therapy for resectable pancreatic can…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating GVAX Pancreas Vaccine with cyclophosphamide in combination with nivolumab and SBRT for borderline resectable panc…